Clinical Trials · NCT00819468

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Name: Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Teduglutide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Shire
Enrollment: 24
Start date: Jul 2007
Locations: 1 site, United States
Primary endpoint: Area Under the Concentration-Time Curve From Time Zero to Time of the Last Measurable Concentration (AUC0-last)

View Teduglutide compound reference